158 related articles for article (PubMed ID: 38503825)
21. HIF-2-dependent expression of stem cell factor promotes metastasis in hepatocellular carcinoma.
Wang X; Dong J; Jia L; Zhao T; Lang M; Li Z; Lan C; Li X; Hao J; Wang H; Qin T; Huang C; Yang S; Yu M; Ren H
Cancer Lett; 2017 May; 393():113-124. PubMed ID: 28153790
[TBL] [Abstract][Full Text] [Related]
22. Deciphering the immune modulation through deep transcriptomic profiling and therapeutic implications of DNA damage repair pattern in hepatocellular carcinoma.
Hong W; Zhang Y; Wang S; Zheng D; Hsu S; Zhou J; Fan J; Zeng Z; Wang N; Ding Z; Yu M; Gao Q; Du S
Cancer Lett; 2024 Feb; 582():216594. PubMed ID: 38135208
[TBL] [Abstract][Full Text] [Related]
23. BRD4 inhibition induces synthetic lethality in ARID2-deficient hepatocellular carcinoma by increasing DNA damage.
He DD; Shang XY; Wang N; Wang GX; He KY; Wang L; Han ZG
Oncogene; 2022 Mar; 41(10):1397-1409. PubMed ID: 35017665
[TBL] [Abstract][Full Text] [Related]
24. 2-Methoxyestradiol synergizes with Erlotinib to suppress hepatocellular carcinoma by disrupting the PLAGL2-EGFR-HIF-1/2α signaling loop.
Zheng S; Ni J; Li Y; Lu M; Yao Y; Guo H; Jiao M; Jin T; Zhang H; Yuan A; Wang Z; Yang Y; Chen Z; Wu H; Hu W
Pharmacol Res; 2021 Jul; 169():105685. PubMed ID: 34022398
[TBL] [Abstract][Full Text] [Related]
25. Nudix hydrolase 1 is a prognostic biomarker in hepatocellular carcinoma.
Ou Q; Ma N; Yu Z; Wang R; Hou Y; Wang Z; Chen F; Li W; Bi J; Ma J; Zhang L; Su Q; Huang X
Aging (Albany NY); 2020 Apr; 12(8):7363-7379. PubMed ID: 32341205
[TBL] [Abstract][Full Text] [Related]
26. Promoter hypermethylation of DNA damage response genes in hepatocellular carcinoma.
Li Z; Zhang H; Yang J; Hao T; Li S
Cell Biol Int; 2012 May; 36(5):427-32. PubMed ID: 21864295
[TBL] [Abstract][Full Text] [Related]
27. Cross talk between oxidative stress and hypoxia via thioredoxin and HIF-2α drives metastasis of hepatocellular carcinoma.
Cao MQ; You AB; Cui W; Zhang S; Guo ZG; Chen L; Zhu XD; Zhang W; Zhu XL; Guo H; Deng DJ; Sun HC; Zhang T
FASEB J; 2020 Apr; 34(4):5892-5905. PubMed ID: 32157720
[TBL] [Abstract][Full Text] [Related]
28. AP-2alpha induces epigenetic silencing of tumor suppressive genes and microsatellite instability in head and neck squamous cell carcinoma.
Bennett KL; Romigh T; Eng C
PLoS One; 2009 Sep; 4(9):e6931. PubMed ID: 19742317
[TBL] [Abstract][Full Text] [Related]
29. DNMT3b/OCT4 expression confers sorafenib resistance and poor prognosis of hepatocellular carcinoma through IL-6/STAT3 regulation.
Lai SC; Su YT; Chi CC; Kuo YC; Lee KF; Wu YC; Lan PC; Yang MH; Chang TS; Huang YH
J Exp Clin Cancer Res; 2019 Nov; 38(1):474. PubMed ID: 31771617
[TBL] [Abstract][Full Text] [Related]
30. A Comprehensive Prognostic Analysis of POLD1 in Hepatocellular Carcinoma.
Tang H; You T; Sun Z; Bai C
BMC Cancer; 2022 Feb; 22(1):197. PubMed ID: 35189839
[TBL] [Abstract][Full Text] [Related]
31. Characterization of genome-wide TFCP2 targets in hepatocellular carcinoma: implication of targets FN1 and TJP1 in metastasis.
Xu X; Liu Z; Zhou L; Xie H; Cheng J; Ling Q; Wang J; Guo H; Wei X; Zheng S
J Exp Clin Cancer Res; 2015 Jan; 34(1):6. PubMed ID: 25609232
[TBL] [Abstract][Full Text] [Related]
32. Osteopontin alters DNA methylation through up-regulating DNMT1 and sensitizes CD133+/CD44+ cancer stem cells to 5 azacytidine in hepatocellular carcinoma.
Gao X; Sheng Y; Yang J; Wang C; Zhang R; Zhu Y; Zhang Z; Zhang K; Yan S; Sun H; Wei J; Wang X; Yu X; Zhang Y; Luo Q; Zheng Y; Qiao P; Zhao Y; Dong Q; Qin L
J Exp Clin Cancer Res; 2018 Jul; 37(1):179. PubMed ID: 30064482
[TBL] [Abstract][Full Text] [Related]
33. Knockdown of THOC1 reduces the proliferation of hepatocellular carcinoma and increases the sensitivity to cisplatin.
Cai S; Bai Y; Wang H; Zhao Z; Ding X; Zhang H; Zhang X; Liu Y; Jia Y; Li Y; Chen S; Zhou H; Liu H; Yang C; Sun T
J Exp Clin Cancer Res; 2020 Jul; 39(1):135. PubMed ID: 32669125
[TBL] [Abstract][Full Text] [Related]
34. RAD51 Inhibition Shows Antitumor Activity in Hepatocellular Carcinoma.
Pan M; Sha Y; Qiu J; Chen Y; Liu L; Luo M; Huang A; Xia J
Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175611
[TBL] [Abstract][Full Text] [Related]
35. Linc-ROR drive adriamycin resistance by targeting AP-2α/Wnt/β-catenin axis in hepatocellular carcinoma.
Shi CJ; Lv MY; Deng LQ; Zeng WQ; Fu WM; Zhang JF
Cell Biol Toxicol; 2023 Aug; 39(4):1735-1752. PubMed ID: 36576707
[TBL] [Abstract][Full Text] [Related]
36. Targeting Mybbp1a suppresses HCC progression via inhibiting IGF1/AKT pathway by CpG islands hypo-methylation dependent promotion of IGFBP5.
Weng X; Wu J; Lv Z; Peng C; Chen J; Zhang C; He B; Tong R; Hu W; Ding C; Cao L; Chen D; Wu J; Zheng S
EBioMedicine; 2019 Jun; 44():225-236. PubMed ID: 31109829
[TBL] [Abstract][Full Text] [Related]
37. The over-expression of survivin enhances the chemotherapeutic efficacy of YM155 in human hepatocellular carcinoma.
Xia H; Chen J; Shi M; Deivasigamani A; Ooi LL; Hui KM
Oncotarget; 2015 Mar; 6(8):5990-6000. PubMed ID: 25714025
[TBL] [Abstract][Full Text] [Related]
38. Overexpressed or hyperactivated Rac1 as a target to treat hepatocellular carcinoma.
Sauzeau V; Beignet J; Vergoten G; Bailly C
Pharmacol Res; 2022 May; 179():106220. PubMed ID: 35405309
[TBL] [Abstract][Full Text] [Related]
39. Targeting cyclin dependent kinase 5 in hepatocellular carcinoma--A novel therapeutic approach.
Ehrlich SM; Liebl J; Ardelt MA; Lehr T; De Toni EN; Mayr D; Brandl L; Kirchner T; Zahler S; Gerbes AL; Vollmar AM
J Hepatol; 2015 Jul; 63(1):102-13. PubMed ID: 25660209
[TBL] [Abstract][Full Text] [Related]
40. Acetyl-11-keto-β-boswellic acid triggers premature senescence via induction of DNA damage accompanied by impairment of DNA repair genes in hepatocellular carcinoma cells in vitro and in vivo.
Wang S; Wang H; Sun B; Li D; Wu J; Li J; Tian X; Qin C; Chang H; Liu Y
Fundam Clin Pharmacol; 2020 Feb; 34(1):65-76. PubMed ID: 31141202
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
